Strides Pharma Science Ltd
Company Profile
Business description
Strides Pharma Science Ltd develops and manufactures a wide range of IP-led niche pharmaceutical products. Its diverse portfolio spans complex generics across multiple dosage forms, including tablets, hard capsules, sachets, liquids, nasal sprays, topicals, and controlled substances. It also manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for its institutional business. The customers for this business include institutionally funded aid projects and procurement agencies. With its R&D, integration, and distribution network, the company brings differentiated products to market across the U.S., Australia, Europe, Africa, and Emerging Markets. Geographically, it generates maximum revenue from North America.
Contact
Bannerghatta Road
Strides House
Bilekahalli
BengaluruKA560076
INDT: +91 8067840000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
3,616
Stocks News & Analysis
stocks
James Hardie transfers of share listing to New York Stock Exchange
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,926.20 | 80.60 | -0.89% |
CAC 40 | 7,763.49 | 59.18 | -0.76% |
DAX 40 | 24,221.74 | 67.77 | -0.28% |
Dow JONES (US) | 44,402.17 | 59.98 | 0.14% |
FTSE 100 | 8,976.97 | 15.15 | -0.17% |
HKSE | 24,994.14 | 168.48 | 0.68% |
NASDAQ | 21,037.81 | 142.16 | 0.68% |
Nikkei 225 | 39,819.11 | 82.08 | -0.21% |
NZX 50 Index | 12,961.51 | 81.11 | 0.63% |
S&P 500 | 6,321.70 | 24.91 | 0.40% |
S&P/ASX 200 | 8,668.20 | 89.00 | -1.02% |
SSE Composite Index | 3,559.79 | 25.31 | 0.72% |